Pediatric Syphilis Medication

  • Author: Muhammad Waseem, MD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Mar 29, 2011
 

Medication Summary

Treponema pallidum is extremely sensitive to penicillin. Primary, secondary, and early latent syphilis are treated with a single IM dose of penicillin G benzathine (50,000 U/kg; not to exceed 2.4 million U). Nonpregnant patients who are allergic to penicillin and have no evidence of neurosyphilis can be treated with either doxycycline or tetracycline.

Incubating syphilis can also be managed with penicillin. Spectinomycin is ineffective for incubating syphilis.

Current recommendations for management of congenital syphilis include administration of IV penicillin G aqueous and IM penicillin G procaine for 10-14 days. Either penicillin regimen is considered adequate to manage congenital syphilis.

Next

Antibiotics

Class Summary

Penicillins are the drug of choice to treat all stages of syphilis. In patients with primary syphilis, doxycycline and tetracycline have shown a high serological treatment success rate, comparable to penicillin.[14]

Penicillin G benzathine (Bicillin L-A)

 

Primary, secondary, and early latent diseases are treated with a single intramuscular (IM) dose of benzathine penicillin G (50,000 U/kg; not to exceed 2.4 million U). It interferes with the synthesis of cell wall mucopeptides during active multiplication, which results in bactericidal activity. It is a spirocheticide with in vivo activity against T pallidum. It also interferes with cell wall mucopeptide synthesis during replication.

Penicillin G procaine

 

Treat congenital infection, either proven or presumed, with 10-14 days of aqueous penicillin G or procaine penicillin G. Procaine penicillin G (50,000 U/kg IM) has been recommended as an alternative to treat congenital syphilis, but adequate cerebrospinal fluid (CSF) concentration may not be consistently achieved.

Penicillin G (Pfizerpen)

 

Penicillin interferes with the synthesis of cell wall mucopeptide during active multiplication, resulting in bactericidal activity against susceptible microorganisms. Aqueous crystalline penicillin G is recommended if congenital syphilis is proved or is highly suspected. The dosage should be based on chronologic, not gestational, age.

Doxycycline (Vibra-Tabs, Vibramycin, Doryx)

 

Doxycycline is a broad-spectrum, synthetically derived bacteriostatic antibiotic in the tetracycline class. It is almost completely absorbed, concentrates in bile, and is excreted in urine and feces as a biologically active metabolite in high concentrations. It inhibits protein synthesis and, thus, bacterial growth by binding to 30S and possibly 50S ribosomal subunits of susceptible bacteria. It may block dissociation of peptidyl t-RNA from ribosomes, causing RNA-dependent protein synthesis to arrest.

Tetracycline

 

Tetracycline is an alternative therapy for syphilis infection. It inhibits bacterial growth by binding to the 30S ribosomal unit, preventing protein synthesis.

Probenecid

 

Probenecid inhibits tubular secretion of penicillin, and it usually increases penicillin plasma levels by any route the antibiotic is administered. A 2- to 4-fold elevation has been demonstrated for various penicillins. It is used as an adjunct to penicillin in late latent and neurosyphilis.

Previous
 
Contributor Information and Disclosures
Author

Muhammad Waseem, MD  Associate Professor of Emergency Medicine in Clinical Pediatrics, Weill Medical College of Cornell University; Consulting Staff, Department of Pediatrics, Bronx Lebanon Hospital; Consulting Staff, Department of Emergency Medicine, Lincoln Medical and Mental Health Center

Muhammad Waseem, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Emergency Physicians, American Heart Association, and American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Muhammad Aslam, MD  Instructor in Pediatrics, Harvard Medical School; Staff Physician, Department of Medicine, Division of Newborn Medicine, Children's Hospital Boston

Muhammad Aslam, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Medical Association, Massachusetts Medical Society, and Southern Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Leslie L Barton, MD  Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References
  1. Centers for Disease Control and Prevention. Congenital syphilis - United States, 2003-2008. MMWR Morb Mortal Wkly Rep. Apr 16 2010;59(14):413-7. [Medline].

  2. Heffelfinger JD, Swint EB, Berman SM, Weinstock HS. Trends in primary and secondary syphilis among men who have sex with men in the United States. Am J Public Health. Jun 2007;97(6):1076-83. [Medline].

  3. Vasquez-Manzanilla O, Dickson-Gonzalez SM, Salas JG, Rodriguez-Morales AJ, Arria M. Congenital syphilis in valera, Venezuela. J Trop Pediatr. Aug 2007;53(4):274-7. [Medline].

  4. Sena AC, Muth SQ, Heffelfinger JD, et al. Factors and the sociosexual network associated with a syphilis outbreak in rural North Carolina. Sex Transm Dis. May 2007;34(5):280-7. [Medline].

  5. Klig JE. Ophthalmologic complications of systemic disease. Emerg Med Clin North Am. Feburary 2008;26(1):217-231. [Medline].

  6. Taiwo SS, Adesiji YO, Adekanle DA. Screening for syphilis during pregnancy in Nigeria: a practice that must continue. Sex Transm Infect. Aug 2007;83(5):357-8. [Medline].

  7. [Guideline] American Academy of Pediatrics, American College of Obstetricians. Guidelines for Perinatal Care. 5th ed. 2002.

  8. [Guideline] Screening for syphilis infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. May 19 2009;150(10):705-9. [Medline].

  9. American Academy of Pediatrics. Syphillis. In: Red Book: Report of the Committee on Infectious Diseases. 26th ed. 2003:595-607.

  10. American Academy of Pediatrics. Syphillis. In: Red Book: Report of the Committee on Infectious Diseases. 29th ed. 2009:639.

  11. Knight CS, Crum MA, Hardy RW. Evaluation of the LIAISON Treponema Assay, a Chemiluminescent Immunoassay for the Diagnosis of Syphilis. Clin Vaccine Immunol. Apr 25 2007;[Medline].

  12. Woznicova V, Valisova Z. Performance of CAPTIA SelectSyph-G enzyme-linked immunosorbent assay in syphilis testing of a high-risk population: analysis of discordant results. J Clin Microbiol. Jun 2007;45(6):1794-7. [Medline].

  13. Kandelaki G, Kapila R, Fernandes H. Destructive osteomyelitis associated with early secondary syphilis in an HIV-positive patient diagnosed by Treponema pallidum DNA polymerase chain reaction. AIDS Patient Care STDS. Apr 2007;21(4):229-33. [Medline].

  14. Wong T, Singh AE, De P. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med. October 2008;121(10):903-908. [Medline].

  15. Bai ZG, Yang KH, Liu YL, et al. Azithromycin vs. benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. Int J STD AIDS. April 2008;19(4):217-221. [Medline].

  16. Chau J, Atashband S, Chang E, Westerberg BD, Kozak FK. A systematic review of pediatric sensorineural hearing loss in congenital syphilis. Int J Pediatr Otorhinolaryngol. March 2009;[Medline].

Previous
Next
 
These photographs show close-up images of gummas observed in tertiary syphilis. Used with permission from Wisdom A. Color Atlas of Sexually Transmitted Diseases. Year Book Medical Publishers Inc; 1989.
These photographs illustrate examples of condylomata lata. The lesions resemble genital warts (condylomata acuminata). Fluids exuding from these lesions are highly infectious. Used with permission from Wisdom A. Color Atlas of Sexually Transmitted Diseases. Year Book Medical Publishers Inc; 1989.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.